MEDULLARY THYROID CANCER
Clinical trials for MEDULLARY THYROID CANCER explained in plain language.
Never miss a new study
Get alerted when new MEDULLARY THYROID CANCER trials appear
Sign up with your email to follow new studies for MEDULLARY THYROID CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy targets aggressive tumors with promising drug and radiation
Disease control Recruiting nowThis study tests whether adding the drug tarlatamab to standard radiation is safe and effective for cancers that have a protein called DLL3. About 30 adults with cancers like melanoma, lung cancer, or glioblastoma will receive the combination. The goal is to find the best timing …
Matched conditions: MEDULLARY THYROID CANCER
Phase: PHASE1, PHASE2 • Sponsor: University of Arizona • Aim: Disease control
Last updated May 26, 2026 05:04 UTC
-
Custom mRNA vaccine takes on rare endocrine cancers
Disease control Recruiting nowThis early study tests a personalized mRNA vaccine (mRNA-0523-L001) in 21 adults with advanced endocrine tumors, such as adrenal, thyroid, or pancreatic cancers, that have not responded to standard treatments. The vaccine is designed to train the immune system to attack each pati…
Matched conditions: MEDULLARY THYROID CANCER
Phase: NA • Sponsor: Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated May 18, 2026 12:07 UTC
-
Scientists track rare thyroid cancer to unlock its secrets
Knowledge-focused Recruiting nowThis study follows children and adults with medullary thyroid cancer (MTC), often linked to a genetic condition called MEN2, to see how the disease grows and changes over time. Researchers will collect blood, tissue, and imaging data during regular visits every 6 to 12 months. No…
Matched conditions: MEDULLARY THYROID CANCER
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 22, 2026 14:05 UTC